Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Almstedt, K; Schmidt, M
Immunonkologie beim Mammakarzinom – von der Diagnose bis zur TherapieOnkologie heute. Bd. 12. 2019 S. 32-36
Heimes, AS; Almstedt, K; Schmidt, M
Immunonkologie beim triple-negativen MammakarzinomFrauenheilkunde up2date. Bd. 13. 2019 S. 339-349
Banys-Paluchowskil, Malgorzata; Krawczyk, Natalia; Friebe, Verena et al.
Immunotherapy for breast cancerGYNAKOLOGE. Bd. 52. H. 5. 2019 S. 343-353
Tannapfel, Andrea; Reinacher-Schick, Anke; Hacker, Ulrich et al.
Immunotherapy: New Options in Gastrointestinal Cancers?VISCERAL MEDICINE. Bd. 35. H. 1. 2019 S. 47-51
McNamara, M. G.; Lopes, A.; Wasan, H. et al.
Impact of anatomic site of biliary tract tumour origin and conditional probability of survival (CS): Results from 15 prospective advanced first-line clinical trialANNALS OF ONCOLOGY. Bd. 30. 2019 S. 274-274
Toelle, Daniela; Hentrich, Marcus; Pelzer, Benedikt W. et al.
Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysisINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY. Bd. 40. H. 10. 2019 S. 1204-1206
Kroeger, Nicolaus; Eikema, Diderik-Jan; Koster, Linda et al.
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemiaBRITISH JOURNAL OF HAEMATOLOGY. Bd. 185. H. 4. 2019 S. 725-732
Sprinzl, Martin F.; Kirstein, Martha M.; Koch, Sandra et al.
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaLIVER CANCER. Bd. 8. H. 5. 2019 S. 387-402
Huber, Yvonne; Pfirrmann, Daniel; Gebhardt, Ines et al.
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise programALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019
Staubitz, J. I.; Musholt, T. J.
Individualization of the surgical procedure in response to overdiagnosis and overtreatment in differentiated thyroid carcinomasPATHOLOGE. 2019